VTGN Long Call Strategy
VTGN (VistaGen Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product candidature also has potential to treat a range of anxiety disorders, including adjustment disorder with anxiety, postpartum anxiety, post-traumatic stress disorder, preprocedural anxiety, and panic disorders. The company's CNS pipeline also comprises PH10, a rapid-onset neuroactive nasal spray, which is in preparation for Phase 2B clinical development as a stand-alone treatment for major depressive disorder (MDD); and AV-101, an oral N-methyl-D-aspartate receptor antagonist, which is in development in combination with oral probenecid as a potential treatment of levodopa-induced dyskinesia, MDD, neuropathic pain, and suicidal ideation. It has contract research and development agreement with Cato Research Ltd.; license agreement with Pherin Pharmaceuticals, Inc.; and license and collaboration agreement with EverInsight Therapeutics Inc. VistaGen Therapeutics, Inc. was founded in 1998 and is headquartered in South San Francisco, California.
VTGN (VistaGen Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $21.5M, a beta of 0.30 versus the broader market, a 52-week range of 0.43-5.14, average daily share volume of 787K, a public-listing history dating back to 2011, approximately 48 full-time employees. These structural characteristics shape how VTGN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.30 indicates VTGN has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long call on VTGN?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current VTGN snapshot
As of May 15, 2026, spot at $0.62, ATM IV 31.80%, IV rank 3.11%, expected move 9.12%. The long call on VTGN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on VTGN specifically: VTGN IV at 31.80% is on the cheap side of its 1-year range, which favors premium-buying structures like a VTGN long call, with a market-implied 1-standard-deviation move of approximately 9.12% (roughly $0.06 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated VTGN expiries trade a higher absolute premium for lower per-day decay. Position sizing on VTGN should anchor to the underlying notional of $0.62 per share and to the trader's directional view on VTGN stock.
VTGN long call setup
The VTGN long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With VTGN near $0.62, the first option leg uses a $0.62 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed VTGN chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 VTGN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $0.62 | N/A |
VTGN long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
VTGN long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on VTGN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on VTGN
Long calls on VTGN express a bullish thesis with defined risk; traders use them ahead of VTGN catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
VTGN thesis for this long call
The market-implied 1-standard-deviation range for VTGN extends from approximately $0.56 on the downside to $0.68 on the upside. A VTGN long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current VTGN IV rank near 3.11% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on VTGN at 31.80%. As a Healthcare name, VTGN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to VTGN-specific events.
VTGN long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. VTGN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move VTGN alongside the broader basket even when VTGN-specific fundamentals are unchanged. Long-premium structures like a long call on VTGN are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current VTGN chain quotes before placing a trade.
Frequently asked questions
- What is a long call on VTGN?
- A long call on VTGN is the long call strategy applied to VTGN (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With VTGN stock trading near $0.62, the strikes shown on this page are snapped to the nearest listed VTGN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are VTGN long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the VTGN long call priced from the end-of-day chain at a 30-day expiry (ATM IV 31.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a VTGN long call?
- The breakeven for the VTGN long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current VTGN market-implied 1-standard-deviation expected move is approximately 9.12%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on VTGN?
- Long calls on VTGN express a bullish thesis with defined risk; traders use them ahead of VTGN catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current VTGN implied volatility affect this long call?
- VTGN ATM IV is at 31.80% with IV rank near 3.11%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.